See inside every stock. Pro
S&P 5007,757▲ 0.58%Nasdaq26,703▲ 1.05%Dow Jones52,856▲ 0.69%Nasdaq 10029,823▲ 1.13%VIX16.68▼ 3.64%US Dollar101.69▼ 0.01%Gold spot4,114▼ 0.44%WTI99.73▲ 2.66%
← 0KTX page
XStocksXray
Market X-Ray report · 21 October 2026

Rapid7, Inc. (0KTX)

London Exchange · UK · prices in USD · close of 21 Oct 2026

Key indicators

Last closeUSD 13.63
52-week range5.00 – 16.90
Return, 1 month / 3 months+9.0% / +39.8%
Return, 1 year / 3 years– / –
TrendUptrend
RSI (14)61
Volatility (1 year)84.4%
Worst drawdown (1 year)-68.9%
Average daily value traded0.09M USD
Dividend yield–

Market X-Ray price-based

57/ 100 · Medium confidence · ahead of 57% of stocks on this exchange
Trend81
Momentum97
Stability (higher is calmer)9
Liquidity29
Income–

Five-year price chart navy: price · brown: 200-day average

4.407.5510.7113.8617.022025-122026-022026-052026-082026-10

About the company

Rapid7 is a cybersecurity company based in Boston that helps organizations find and address weaknesses in their computer systems. Its software scans networks and applications for vulnerabilities, manages security incidents, and supports penetration testing, with products such as Nexpose and Metasploit. Customers are mainly businesses and public organizations that use these tools to monitor their security posture and respond to threats. The company also offers cloud-based security analytics through its platform.

The shares are listed on the London Exchange in UK under the code 0KTX, and the price on this page is in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Rapid7, Inc. (0KTX) trades on the London Exchange in UK. It last closed at USD 13.63 on 21 October 2026.

Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 1,618 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Rapid7, Inc. (0KTX)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend81 · StrongTrading above its long-term averages and near its highs.
Above 200-day average46.6%
From 52-week high-16.6%
Momentum97 · StrongRising faster than most stocks on this exchange.
3-month return39.8%
6-month return132.6%
12-month return, skipping the last month–
Stability (higher is calmer)9 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)84.4%
Worst drawdown, 1 year (smaller is calmer)-68.9%
Liquidity29 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.09M USD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week+10.0%
1 month+9.0%
3 months+39.8%
6 months+132.6%
1 year–
3 years–
5 years–

Signals

50-day / 200-day average12.28 / 9.30
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.89

Technical summary

DailyStrongly bullish11 bullish · 3 neutral · 1 bearish
WeeklyStrongly bullish6 bullish · 1 neutral · 0 bearish
MonthlyStrongly bullish1 bullish · 0 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 22 Oct 2026